Cangene Corporation
Cangene Corporation company makes plasma products known as hyperimmunes, which are antibody preparations and recombinant biopharmaceuticals made by introducing a gene in a host organism. Cangene's drugs are used to treat plasma-derived disorders, including the blood clotting disorder thrombocytopenic purpura and hemolytic disease of the newborn, which occurs when a fetus' blood type is incompatible with its mother's. Cangene has several approved products and is developing others, mainly in the areas of infectious disease and biodefense. Generic giant Apotex owns more than 80% of Cangene.
Contact Details
Office Address
Cangene Corporation
155 Innovation Drive
Winnipeg, MB, Canada R3T5Y3
Phone: (204) 275-4200
Fax: (204) 269-7003
Executives
Chairman
Jacob M. (Jack) Kay
President, CEO, and Director
John Langstaff